ArticleScientific reports2025
The estimated incidence of uterine corpus cancers among permanent residents in mainland China using Bayesian spatial modeling.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Cancer registration in mainland China traditionally focuses on household-registered residents (HRR) and does not include the migrant population among permanent residents (PR), leading to significant selection bias. Estimating incidence among permanent residents provides a less biased and more representative measure of the true incidence. We developed a Bayesian Integrated Nested Laplace Approximation with Stochastic Partial Differential Equation model, incorporating inter-provincial migrant population weights to estimate uterine corpus cancer incidence among permanent residents. The findings revealed a substantial interprovincial migrant population of 67,509,881 individuals, with Shanghai and Beijing showing relatively high difference proportions of 39.6% and 37.0%, respectively. Nationally, the differences in estimated uterine corpus cancer incidence between female PR and HRR were marginal, ranging from 0.2/100,000 in Qinghai to - 0.4/100,000 in Shanghai. The analysis estimated that the provinces with the largest differences between incident cases among female PR and HRR were Henan (- 899 cases, 15.7%) and Guangdong (630 cases, 13.7%). This research holds significant implications for countries relying on HRR-based cancer registration system, particularly those contending with substantial migrant populations. The estimated differences in uterine corpus cancer incidence between PR and HRR provide crucial data support for optimizing prevention strategies and enabling precise allocation of regional healthcare resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.